Quarterly Updates26 May 2026, 05:31 pm
P&G Health FY26: Sales up 16%, PAT up 30%
AI Summary
Procter & Gamble Health Ltd announced its financial results for the fourth quarter and fiscal year ended March 31, 2026. Sales for the quarter stood at ₹365 crores, up 20% YoY, while Profit After Tax (PAT) was ₹95 crores, up 55% YoY. The company reported sales of ₹1385 crores and PAT of ₹327 crores for the 12-month financial year, up 16% and 30% respectively, compared to the comparable 12-month period last year. The Board recommended a final dividend of ₹45 per share, bringing the total dividend payout for the fiscal to ₹205 per share.
Key Highlights
- Q4 Sales up 20% to ₹365 crores, PAT up 55% to ₹95 crores YoY.
- FY26 Sales at ₹1385 crores, up 16%, and PAT at ₹327 crores, up 30% YoY.
- Final dividend of ₹45 per share recommended, total dividend ₹205 per share.
- Company launched Livogen Iron Gummies and Neurobion Nerve Pain Relief Cream.
- P&G Sehat initiative impacted over 15 lakh lives in underserved communities.
Price Impact
More from PGHL